These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 38848146)
1. Overexpression of zinc finger DHHC-type containing 1 is associated with poor prognosis and cancer cell growth and metastasis in uterine corpus endometrial carcinoma. Jiang N; Li D; Han Y; Luo ZG; Liu LB Aging (Albany NY); 2024 Jun; 16(11):9784-9812. PubMed ID: 38848146 [TBL] [Abstract][Full Text] [Related]
2. Development and Clinical Validation of Novel 8-Gene Prognostic Signature Associated With the Proportion of Regulatory T Cells by Weighted Gene Co-Expression Network Analysis in Uterine Corpus Endometrial Carcinoma. Liu J; Geng R; Yang S; Shao F; Zhong Z; Yang M; Ni S; Cai L; Bai J Front Immunol; 2021; 12():788431. PubMed ID: 34970268 [TBL] [Abstract][Full Text] [Related]
3. A comprehensive analysis of CEBPA on prognosis and function in uterine corpus endometrial carcinoma. Wang J; Huang W; Chai S; Gan J; Zeng Y; Long P; Pang L Sci Rep; 2024 Oct; 14(1):23773. PubMed ID: 39390018 [TBL] [Abstract][Full Text] [Related]
4. KDM4B, a potential prognostic biomarker revealed by large-scale public databases and clinical samples in uterine corpus endometrial carcinoma. Zhang M; Liu Y; Hou S; Wang Y; Wang C; Yin Y; Chen X Mol Omics; 2022 Jul; 18(6):506-519. PubMed ID: 35485290 [TBL] [Abstract][Full Text] [Related]
5. Pan-Cancer Gene Analysis of m6A Modification and Immune Infiltration in Uterine Corpus Endometrial Carcinoma. Xie BF; Xia Y; Lin DH; Lian B; Zhang ML; Liu L; Qin CR Comput Intell Neurosci; 2022; 2022():6530884. PubMed ID: 36199963 [TBL] [Abstract][Full Text] [Related]
6. Development of a necroptosis-related prognostic model for uterine corpus endometrial carcinoma. Zhang Q; Luo Y; Zhang S; Huang Q; Liu G Sci Rep; 2024 Feb; 14(1):4257. PubMed ID: 38383747 [TBL] [Abstract][Full Text] [Related]
7. ALDH2 promotes uterine corpus endometrial carcinoma proliferation and construction of clinical survival prognostic model. Cui YQ; Xiang Y; Meng F; Ji CH; Xiao R; Li JP; Dai ZT; Liao XH Aging (Albany NY); 2021 Oct; 13(20):23588-23602. PubMed ID: 34670872 [TBL] [Abstract][Full Text] [Related]
8. Identification of an eight-m6A RNA methylation regulator prognostic signature of uterine corpus endometrial carcinoma based on bioinformatics analysis. Miao C; Fang X; Chen Y; Zhao Y; Guo Q Medicine (Baltimore); 2021 Dec; 100(49):e27689. PubMed ID: 34889221 [TBL] [Abstract][Full Text] [Related]
9. Construction of N-7 methylguanine-related mRNA prognostic model in uterine corpus endometrial carcinoma based on multi-omics data and immune-related analysis. Zhao J; Zou J; Jiao W; Lin L; Wang J; Lin Z Sci Rep; 2022 Nov; 12(1):18813. PubMed ID: 36335189 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of ESRRA in Endometrial Cancer. Wang S; Huo X Technol Cancer Res Treat; 2021; 20():1533033821992083. PubMed ID: 33525981 [TBL] [Abstract][Full Text] [Related]
11. LHX1 as a potential biomarker regulates EMT induction and cellular behaviors in uterine corpus endometrial carcinoma. Tian Y; Wen F; Wang S; Lv N Clinics (Sao Paulo); 2022; 77():100103. PubMed ID: 36116266 [TBL] [Abstract][Full Text] [Related]
12. A 7-lncRNA signature predict prognosis of Uterine corpus endometrial carcinoma. Ouyang D; Li R; Li Y; Zhu X J Cell Biochem; 2019 Oct; 120(10):18465-18477. PubMed ID: 31168849 [TBL] [Abstract][Full Text] [Related]
13. Identification of Five m6A-Related lncRNA Genes as Prognostic Markers for Endometrial Cancer Based on TCGA Database. Shan L; Lu Y; Xiang CC; Zhu X; Zuo ED; Cheng X J Immunol Res; 2022; 2022():2547029. PubMed ID: 35571565 [TBL] [Abstract][Full Text] [Related]
14. ZNF554 Inhibits Endometrial Cancer Progression via Regulating RBM5 and Inactivating WNT/β-Catenin Signaling Pathway. Zhu CC; Sun HL; Long TF; Lyu YY; Liu JL; Ni GT Curr Med Sci; 2024 Apr; 44(2):406-418. PubMed ID: 38619681 [TBL] [Abstract][Full Text] [Related]
15. Identifying immune subtypes of uterine corpus endometrial carcinoma and a four-paired-lncRNA signature with immune-related lncRNAs. Li N; Yu K; Lin Z; Zeng D Exp Biol Med (Maywood); 2022 Feb; 247(3):221-236. PubMed ID: 34704492 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathological role of Cyclin A2 in uterine corpus endometrial carcinoma: Integration of tissue microarrays and ScRNA-Seq. Mo WJ; Liang ZQ; Huang JZ; Huang ZG; Zhi ZF; Chen JH; Chen G; Zeng JJ; Feng ZB Int J Biol Markers; 2024 Jun; 39(2):168-183. PubMed ID: 38646803 [TBL] [Abstract][Full Text] [Related]
17. High expression of the ferroptosis-associated MGST1 gene in relation to poor outcome and maladjusted immune cell infiltration in uterine corpus endometrial carcinoma. Yan J; Ye G; Shao Y J Clin Lab Anal; 2022 Apr; 36(4):e24317. PubMed ID: 35218676 [TBL] [Abstract][Full Text] [Related]
18. Identification of an Immune-Related LncRNA Prognostic Signature in Uterine Corpus Endometrial Carcinoma Patients. Sun XX; Wen HQ; Zhan BX; Yang P Clin Lab; 2021 Nov; 67(11):. PubMed ID: 34758230 [TBL] [Abstract][Full Text] [Related]
19. A comparative analysis indicates SLC7A11 expression regulate the prognostic value of KEAP1-NFE2L2-CUL3 mutations in human uterine corpus endometrial carcinoma. Namani A; Veeraiyan D; Patra T Free Radic Biol Med; 2024 Sep; 222():223-228. PubMed ID: 38876457 [TBL] [Abstract][Full Text] [Related]
20. Risk prediction model of uterine corpus endometrial carcinoma based on immune-related genes. Sang Q; Yang L; Zhao H; Zhao L; Xu R; Liu H; Ding C; Qin Y; Zhao Y BMC Womens Health; 2024 Jul; 24(1):429. PubMed ID: 39068426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]